InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Albanna Rowena, Chief Executive Officer. Officer active across 1 companies, notably Aditx Therapeutics, Inc.. In total, 4 filings have been recorded. Total volume traded: €2k. The latest transaction was filed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
075,000 shares0
Common Stock
SEC:0001213900-21-031447·
075,000 shares0
Common Stock
SEC:0001213900-21-031447:0·
€1,199500 shares@ €2.3981100.0% of flow
Common Stock
SEC:0001213900-21-030429·
Ideal exit: 26 Feb 2022 (T+270)
€1,199500 shares@ €2.398156.64% mcap50.0% of flow
Common Stock
SEC:0001213900-21-030429:0·
Ideal exit: 26 Feb 2022 (T+270)
4 of 4 declarations
About Albanna Rowena
Rowena Albanna is the Chief Operating Officer at Aditx Therapeutics, Inc. She is responsible for the daily operations of the company and the implementation of operational strategies. Her experience in the biopharmaceutical sector enables her to effectively lead growth initiatives.
